Legal Representation
Attorney
Andrew V. Galway
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 18, 2008 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 18, 2008 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 13, 2007 | EEXT | I | TEAS EXTENSION RECEIVED | Loading... |
| Oct 13, 2007 | EXT2 | S | EXTENSION 2 FILED | Loading... |
| Oct 13, 2007 | EX2G | S | EXTENSION 2 GRANTED | Loading... |
| Apr 15, 2007 | EEXT | I | TEAS EXTENSION RECEIVED | Loading... |
| Apr 15, 2007 | EXT1 | S | EXTENSION 1 FILED | Loading... |
| Apr 15, 2007 | EX1G | S | EXTENSION 1 GRANTED | Loading... |
| Oct 17, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 25, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 5, 2006 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jun 9, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jun 2, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 26, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 24, 2006 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 24, 2006 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 24, 2006 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 15, 2006 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 15, 2006 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 10, 2006 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 10, 2005 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for the treatment of cancers, infectious diseases, acne, gastrointestinal tract diseases, central nervous system diseases, auto-immune diseases, muscalo-skeletal disorders, endocrine diseases including diabetes, genito-urinary system diseases, respiratory diseases, namely, asthma and chronic obstructive pulmonary disease, allergies, allergic rhinitis, ophthalmic diseases, obstetrical and gynecological diseases, neoplastic disorders, pain, inflammation, age-related disorders, migraines, obesity, immunological disorders, bacterial disorders, viral disorders, fungal disorders and pharmaceutical dressings for wound management and skin disorders
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"